AspenBio Pharma Inc reported conclusions from its pre-planned, independent, interim analysis of the company’s ongoing supplemental clinical trial of AppyScore.
Read MoreAgendia announces that it has received the Clinical Laboratory Permit from the New York State Department of Health. The New York State permit allows the company to receive commercial samples of MammaPrint, its FDA-cleared breast cancer recurrence test.
Read More
Transgenomic Inc announces that it has completed a preliminary study with a leading pharmaceutical company that validates the use of its licensed COLD-PCR technology to detect colorectal tumor-associated KRAS mutations that determine efficacy of recently developed therapies.
Read MoreQIAGEN announced that its wholly owned subsidiary DxS has acquired the global and exclusive license for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays.
Read More